Article Versions Notes

Bareng OT, Moyo S, Mudanga M, Sebina K, Koofhethile CK, Choga WT, Moraka NO, Maruapula D, Gobe I, Motswaledi MS, et al. Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana. Viruses. 2024; 16(5):720. https://doi.org/10.3390/v16050720

Bareng, Ontlametse T., Sikhulile Moyo, Mbatshi Mudanga, Kagiso Sebina, Catherine K. Koofhethile, Wonderful T. Choga, Natasha O. Moraka, Dorcas Maruapula, Irene Gobe, Modisa S. Motswaledi, and et al. 2024. "Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana" Viruses 16, no. 5: 720. https://doi.org/10.3390/v16050720

Bareng, O. T., Moyo, S., Mudanga, M., Sebina, K., Koofhethile, C. K., Choga, W. T., Moraka, N. O., Maruapula, D., Gobe, I., Motswaledi, M. S., Musonda, R., Nkomo, B., Ramaabya, D., Chebani, T., Makuruetsa, P., Makhema, J., Shapiro, R., Lockman, S., & Gaseitsiwe, S. (2024). Low-Level Viremia among Adults Living with HIV on Dolutegravir-Based First-Line Antiretroviral Therapy Is a Predictor of Virological Failure in Botswana. Viruses, 16(5), 720. https://doi.org/10.3390/v16050720